• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDACTA INTERNATIONAL SA QUADRA H FEMORAL STEMS; QUADRA LATERIZED HAP 12/14 S6

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDACTA INTERNATIONAL SA QUADRA H FEMORAL STEMS; QUADRA LATERIZED HAP 12/14 S6 Back to Search Results
Model Number 01.12.036
Medical Device Problem Code Loss of Osseointegration (2408)
Health Effect - Clinical Code Aseptic loosening (4883)
Date of Event 03/11/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Batch review performed on 18 june 2025.(b)(4) items manufactured and released on 17/07/2019.Expiration date: 06/07/2024.No anomalies found related to the problem.To date, (b)(4) items of the same lot have been sold with no similar reported event during the period of review.Visual inspection performed by r&d department looking at the stem body, an opaque white film is visible on approximately half of the stem length.It is not possible to identify if this film is ha or bone residual, or a combined effect.Absorption of ha from the stem body can indicate that metabolic activity was taking place and that, presumably, adequate bone contact was achieved at the time of surgery.Some signs of damage and scratches are present on the neck of the explanted stem, which is likely due to the revision surgery and not relevant to the reported issue.Based on the analysis completed and information available, it is not possible to identify the root cause of the stem loosening reported.Root cause: based on the information available no definitive root cause can be established, while there is no indication that any potential issue with the device may have caused or contributed to the event, and the device history record review does not indicate any potential manufacturing related issue.
 
Event or Problem Description
Revision due to aseptic stem loosening performed about 5 years and 3 months after the primary surgery.Stem, head, and liner revised.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUADRA H FEMORAL STEMS
Common Device Name
QUADRA LATERIZED HAP 12/14 S6
Manufacturer (Section D)
MEDACTA INTERNATIONAL SA
strada regina
castel san pietro, switzerland 6874
SZ  6874
Manufacturer (Section G)
MEDACTA INTERNATIONAL SA
strada regina
castel san pietro, switzerland 6874
SZ   6874
Manufacturer Contact
marco giannessi
strada regina
castel san pietro, switzerland 6874
SZ   6874
MDR Report Key22380967
Report Number3005180920-2025-00631
Device Sequence Number9436838
Product Code JDI
UDI-Device Identifier07630030802188
UDI-Public07630030802188
Combination Product (Y/N)N
Initial Reporter CountrySZ
PMA/510(K) Number
K082792
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 07/02/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/06/2024
Device Model Number01.12.036
Device Lot Number1902350
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/02/2025
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/11/2025
Initial Report FDA Received Date07/02/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/17/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-